Akso Health Group
5 hedge funds and large institutions have $145K invested in Akso Health Group in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0.16% less ownership
Funds ownership: 0.72% → 0.56% (-0.16%)
29% less funds holding
Funds holding: 7 → 5 (-2)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
68% less capital invested
Capital invested by funds: $448K → $145K (-$303K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$7.34K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$342 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$39.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$21K |
| 3 |
Millennium Management
New York
|
-$14K |
| 4 |
Two Sigma Investments
New York
|
-$4.84K |
AHG Hedge Fund Activity: Q4 2022 in Review
5 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q4 2022, worth a combined $145K — down 68% from $448K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of AHG and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $7.34K. The largest seller was Renaissance Technologies, cutting an estimated $39.2K.
- 5 institutional investors held Akso Health Group (AHG) as of Q4 2022, down from 7 in Q3 2022.
- Funds reported $145K of Akso Health Group stock for Q4 2022, down 68% quarter-over-quarter.
- 1 fund opened new Akso Health Group positions in Q4 2022 and 3 closed out, a net change of -2 holders.
- The largest Akso Health Group buyer in Q4 2022 was Two Sigma Securities, an estimated $7.34K added.
- The largest Akso Health Group seller in Q4 2022 was Renaissance Technologies, an estimated $39.2K sold.
Based on aggregated 13F filings for Q4 2022.